Table 4.

Cox proportional hazards regression analysis of secondary outcomes.

Events	The dapagliflozin group	The control group	Hazard ratio (95% CI)	p
CV death or for CV events hospitalisation	8/144	19/141	0.397 (0.174–0.907)	0.028
CV death or hospitalisation for HF	4/144	10/141	0.383 (0.120–1.222)	0.100
Onset of CV death	0/144	2/141	NA
Hospitalisation for CV events	8/144	19/141	0.397 (0.174–0.907)	0.028
Hospitalisation for HF	4/144	10/141	0.383 (0.120–1.222)	0.100
Death from all causes	3/144	5/141	0.566 (0.135–2.369)	0.440
Hospitalisation for all causes	25/144	38/141	0.591 (0.357–0.979)	0.040
Additional change in prescriptions for HF	11/144	30/141	0.321 (0.161–0.642)	0.001
New-onset atrial fibrillation and/or atrial flutter	2/144	1/141	1.952 (0.177–21.526)	0.590

CV = cardiovascular; HF = heart failure; CI = confidence interval.